Bionexus Gene Lab CORP (BGLC) — DEF 14A Filings
All DEF 14A filings from Bionexus Gene Lab CORP. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
BioNexus Gene Lab Sets Virtual Annual Meeting, Seeks Director Re-election
— Dec 3, 2025 Risk: low
BioNexus Gene Lab Corp. (BGLC) is holding its Annual Meeting of Stockholders on December 24, 2025, virtually at 9:00 a.m. Eastern Time. Key proposals include th -
BioNexus Gene Lab Corp Files Definitive Proxy Statement
— Feb 27, 2025 Risk: low
BioNexus Gene Lab Corp. filed a Definitive Proxy Statement (DEF 14A) on February 27, 2025, for the fiscal year ending December 31, 2024. The filing, with SEC fi -
BioNexus Gene Lab Corp Files Definitive Proxy Statement
— Sep 16, 2024 Risk: low
BioNexus Gene Lab Corp. filed a Definitive Proxy Statement (DEF 14A) on September 16, 2024, for the fiscal year ending December 31, 2024. The company, incorpora
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX